Filing Details

Accession Number:
0001562180-22-004950
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-06-08 21:27:38
Reporting Period:
2022-05-31
Accepted Time:
2022-06-08 21:27:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1831363 Terns Pharmaceuticals Inc. TERN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1762316 Vel Senthil Sundaram C/O Terns Pharmaceuticals, Inc.
1065 East Hillsdale Blvd., Suite 100
Foster City CA 94404
Chief Executive Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-05-31 7,656 $1.47 7,656 No 5 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 P Direct
Footnotes
  1. Includes the purchase of 7,656 shares under the Terns Employee Stock Purchase Plan on May 31, 2022.